m2p-labs GmbH, a Baesweiler near Aachen, Germany-based global manufacturer of microbioreactors, closed a financing round.
The round was led by new investor Fidura Private Equity Fonds (which acquired a total stake of 27.61% in the company), with participation from High-Tech-Gründerfonds.
The company intends to use the funds to further expand its technology with new developments and product improvements, particularly in the field of microscale process control (fed-batch and pH control) and automation of its BioLector®, and to increase its global sales network, especially in the USA and Asia.
Co-founded in 2005 by and Frank Kensy and Carsten Müller, m2p-labs (“m2p” stands for “from microreactor to process”) is engaged in the development and sales of lab analysis systems (microbioreactors) to carry out high throughput test series in the field of cellular screening and bioprocess development. The company focuses on microreaction and automated solutions for screening and bioprocess development. Commercialized products include the BioLector® and the FlowerPlate®, which provide an intelligent micro fermentation platform to enable the biotechnology, chemical and pharmaceutical industry to increase their number and information of microbial and cell culture experiments.
Customers include pharmaceutical and chemical companies, universities (ETH Zürich, RWTH Aachen, University College London and Imperial College London) and research institutions such as the Jülich Research Centre.
FinSMEs
07/11/2013